Levocetirizine during pregnancy and lactation, Levocetirizine category by FDA, its use during pregnancy and lactation its teratogenic effects are described.
Small amount of drug excrete into breast milk, if required low dose should be prescribed.
Levocetirizine during pregnancy and lactation | |
Pregnancy | Category B ( by FDA ) Category B ( AU TGA ) |
| Levocetirizine crosses the placenta, no evidence of teratogenicity or harmful effects by use of this drug, animal studies failed to reveal adverse reaction during pregnancy, |
Breast feeding | Levocetirizine excretes into breastmilk in small quantities, effect on nursing infant unknown, use with caution. |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.